{"id":"Rome_IV_Diagnostic_Criteria_for_Functional_Pancreatic_Sphincter_of_Oddi_Disorder.v0.0.3","gdl_version":"2.0","concept":"gt0001","language":{"original_language":"ISO_639-1::en"},"description":{"original_author":{"name":"Umiah Gohar","email":"umiah.gohar@cambio.se","organisation":"Cambio CDS","date":"2025-03-19"},"lifecycle_state":"Author draft","details":{"en":{"id":"en","keywords":["rome","iv","diagnostic","criteria","functional","pancreatic","sphincter","oddi","disorder","SOD"],"copyright":"© Cambio CDS","misuse":"Not to be used in patients with:\n\n- Pancreatic type pain without objective evidence of pancreatitis.\n- Single episode of idiopathic pancreatitis.\n- Gallstones or sludge on imaging.\n- Culprit drugs associated with pancreatitis (including over the counter, supplements, narcotics).","use":"Used in patients with recurrent episodes of pancreatitis with characteristic pain and appropriate lab elevations. Other common etiologies of pancreatitis must be excluded with a negative endoscopic ultrasound (EUS). \n\n- Helps to provide a diagnosis and treatment strategy in patients with recurrent debilitating pancreatitis otherwise without explanation.\n- Helps guide conversations with patients regarding treatment option that has both procedural risk but also potential therapeutic benefit if criteria met.","purpose":"To assess the  Rome IV criteria for the diagnosis of Functional Pancreatic Sphincter of Oddi Disorder (SOD)."}},"other_details":{"en":"Official Rome IV criteria for the diagnosis of functional pancreatic sphincter of oddi disorder.","references":"Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES. Rome IV. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology. 2016 Feb 19:S0016-5085(16)00224-9. doi: 10.1053/j.gastro.2016.02.033. Epub ahead of print. PMID: 27144629.\n\nAziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. Am J Gastroenterol. 2018 Jan;113(1):86-96. doi: 10.1038/ajg.2017.421. Epub 2017 Nov 14. PMID: 29134969."},"other_contributors":[]},"definition":{"data_bindings":{"gt0003":{"id":"gt0003","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.rome_iv__diagnostic_criteria_for_functional_pancreatic_sphincter_of_oddi_disorder.v0","template_id":"openEHR-EHR-OBSERVATION.rome_iv__diagnostic_criteria_for_functional_pancreatic_sphincter_of_oddi_disorder.v0","elements":{"gt0004":{"id":"gt0004","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"},"gt0005":{"id":"gt0005","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0005]"},"gt0006":{"id":"gt0006","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0006]"},"gt0007":{"id":"gt0007","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0007]"}}},"gt0008":{"id":"gt0008","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.rome_iv_diagnostic_criteria_assessment.v0","template_id":"openEHR-EHR-EVALUATION.rome_iv_diagnostic_criteria_assessment.v0","elements":{"gt0009":{"id":"gt0009","path":"/data[at0001]/items[at0008]"}}}},"templates":{},"rules":{"gt0002":{"id":"gt0002","priority":2,"then":["$gt0009|Diagnostic Result| = local::at0010|Positive|"],"when":["$gt0004|Documented recurrent episodes of pancreatitis (typical pain with amylase or lipase >3 times normal and/or imaging evidence of acute pancreatitis)| == true","$gt0005|Other etiologies of pancreatitis excluded| == true","$gt0006|Negative endoscopic ultrasound| == true","$gt0007|Abnormal sphincter manometry| == true"]},"gt0010":{"id":"gt0010","priority":1,"then":["$gt0009|Diagnostic Result| = local::at0009|Negative|"],"when":["( $gt0004|Documented recurrent episodes of pancreatitis (typical pain with amylase or lipase >3 times normal and/or imaging evidence of acute pancreatitis)| != true || $gt0005|Other etiologies of pancreatitis excluded| != true || $gt0006|Negative endoscopic ultrasound| != true || $gt0007|Abnormal sphincter manometry| != true )"]}}},"ontology":{"term_definitions":{"en":{"id":"en","terms":{"gt0001":{"id":"gt0001","text":"Rome IV Diagnostic Criteria for Functional Pancreatic Sphincter of Oddi Disorder (SOD)","description":"Official Rome IV criteria for the diagnosis of functional pancreatic sphincter of oddi disorder.\n\nTo fulfill the Rome IV criteria for pancreatic sphincter of oddi disorder, patient must have the following:\n\n- Documented recurrent episodes of pancreatitis (typical pain with amylase or lipase >3 times normal and/or imaging evidence of acute pancreatitis).\n- Other etiologies of pancreatitis excluded.\n- Negative endoscopic ultrasound.\n- Abnormal sphincter manometry."},"gt0003":{"id":"gt0003","text":"openEHR-EHR-OBSERVATION.rome_iv__diagnostic_criteria_for_functional_pancreatic_sphincter_of_oddi_disorder.v0"},"gt0004":{"id":"gt0004","text":"Documented recurrent episodes of pancreatitis (typical pain with amylase or lipase >3 times normal and/or imaging evidence of acute pancreatitis)"},"gt0005":{"id":"gt0005","text":"Other etiologies of pancreatitis excluded"},"gt0006":{"id":"gt0006","text":"Negative endoscopic ultrasound"},"gt0007":{"id":"gt0007","text":"Abnormal sphincter manometry"},"gt0008":{"id":"gt0008","text":"openEHR-EHR-EVALUATION.rome_iv_diagnostic_criteria_assessment.v0"},"gt0009":{"id":"gt0009","text":"Diagnostic Result"},"gt0002":{"id":"gt0002","text":"Set Diagnostic result to Positive","description":""},"gt0010":{"id":"gt0010","text":"Set Diagnostic result to Negative","description":""}}}},"term_bindings":{}}}